Firms
Alexandria Venture Investments
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Create Medicines$122M · 2026-05-14
Create Medicines$122M · 2026Dispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Remix Therapeutics$60M · 2024-01-03
Tome Biosciences$213M · 2023-12-12
Bitterroot Bio$145M · 2023-06-07
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
Paratus Sciences$— · 2023-02-28Bitterroot$145M · 2023
Aspen Neuroscience$147M · 2022-05-09
Pheast Therapeutics$76M · 2022-04-26
Mozart Therapeutics$55M · 2021-10-26
Neumora Therapeutics, Inc.$— · 2021-10-07
Encodia$75M · 2021-01-27
Remix Therapeutics$81M · 2020-12-08
Autobahn Therapeutics$76M · 2020-06-09
Aspen Neuroscience$6M · 2019-12-12
Encoded Therapeutics$104M · 2019-06-26
Vividion Therapeutics$82M · 2019-04-30Karuna Therapeutics$82M · 2019-03-18
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11Magnolia Neurosciences$31M · 2018-08-14
Nohla Therapeutics$45M · 2018-05-15
Codiak Biosciences$76M · 2017-11-29
LifeMine Therapeutics$55M · 2017-09-18Nohla Therapeutics$— · 2016-11-29
Petra Pharma$48M · 2016-01-06
Codiak Biosciences$80M · 2015-11-17
Codiak Biosciences$61M · Unknown date
Boragen$10M · Unknown date
ImmuneID$50M · Unknown date
Vividion$82M · Unknown date
Rome$72M · Unknown date
AiRNA$60M · Unknown date
AiRNA$155M · Unknown date
Metacrine$65M · Unknown date
SonoThera$125M · Unknown date
8VC
Create Medicines$122M · 2026-05-14
Alloy Therapeutics$40M · 2026-04
Create Medicines$122M · 2026
Alloy Therapeutics$40M · 2026
Myeloid Therapeutics$73M · 2023-05-18
Alloy Therapeutics$75M · 2021-04-02
Alloy Therapeutics$75M · 2021
Alloy Therapeutics$40M · Unknown date
Alloy Therapeutics$40M · Unknown date
Eli Lilly and Company
TRexBio$50M · 2026-01-27
TRexBio$84M · 2024-11-13
IGGENIX$40M · 2023-02-06
TRexBio$85M · 2022-03-08
Fountain Therapeutics$15M · 2021-11-18Magnolia Neurosciences$31M · 2018-08-14
Petra Pharma$48M · 2016-01-06
Gaingels
Alloy Therapeutics$40M · 2026-04
Alloy Therapeutics$40M · 2026
Seismic Therapeutic$121M · 2023
Alloy Therapeutics$75M · 2021-04-02
Alloy Therapeutics$75M · 2021
Alloy Therapeutics$40M · Unknown date
Alloy Therapeutics$40M · Unknown date
Casdin Capital
Remix Therapeutics$60M · 2024-01-03
Orbital Therapeutics$270M · 2023-04-26
Vividion Therapeutics$82M · 2019-04-30
Codiak Biosciences$76M · 2017-11-29
Vividion$82M · Unknown date
Rome$72M · Unknown date
Founders Fund
Alloy Therapeutics$40M · 2026-04
Alloy Therapeutics$40M · 2026
Alloy Therapeutics$75M · 2021-04-02
Alloy Therapeutics$75M · 2021
Alloy Therapeutics$40M · Unknown date
Alloy Therapeutics$40M · Unknown date
GV
Tome Biosciences$213M · 2023-12-12
Bitterroot Bio$145M · 2023-06-07
Seismic Therapeutic$121M · 2023Bitterroot$145M · 2023
Encodia$75M · 2021-01-27
LifeMine Therapeutics$55M · 2017-09-18
Polaris Partners
TRexBio$50M · 2026-01-27
TRexBio$84M · 2024-11-13
Tome Biosciences$213M · 2023-12-12
Paratus Sciences$— · 2023-02-28
TRexBio$85M · 2022-03-08
Metacrine$65M · Unknown date
Khosla Ventures
IGGENIX$40M · 2023-02-06
Fountain Therapeutics$15M · 2021-11-18
IGGENIX$25M · 2021-07-27
NextVivo$7M · 2021-01-01NextVivo$7M · 2021
Pfizer Ventures
TRexBio$50M · 2026-01-27
TRexBio$84M · 2024-11-13
TRexBio$85M · 2022-03-08Magnolia Neurosciences$31M · 2018-08-14
Petra Pharma$48M · 2016-01-06
Amgen Ventures
Enlaza Therapeutics$100M · 2024-04-30
Aitia$28M · 2019-07-09
Enlaza Therapeutics$100M · Unknown date
Enlaza$100M · Unknown date
Catalio Capital Management
Georgiamune$75M · 2023
Odyssey Therapeutics$168M · 2022-10-13
Pheast Therapeutics$76M · 2022-04-26
Neumora Therapeutics, Inc.$— · 2021-10-07
Celgene
Aitia$28M · 2019-07-09
Vividion Therapeutics$82M · 2019-04-30Nohla Therapeutics$45M · 2018-05-15
Vividion$82M · Unknown date
Echo
Alloy Therapeutics$40M · 2026-04
Alloy Therapeutics$40M · 2026
Alloy Therapeutics$40M · Unknown date
Alloy Therapeutics$40M · Unknown date
Johnson & Johnson Innovation – JJDC
TRexBio$50M · 2026-01-27
TRexBio$84M · 2024-11-13
Arialys Therapeutics$58M · 2023-09-12
TRexBio$85M · 2022-03-08
Mirae Asset
Aspen Neuroscience$147M · 2022-05-09
Vividion Therapeutics$82M · 2019-04-30
Vividion$82M · Unknown date
Rome$72M · Unknown date
Mubadala Ventures
Georgiamune$75M · 2023
Alloy Therapeutics$75M · 2021
Vividion Therapeutics$82M · 2019-04-30
Vividion$82M · Unknown date
Newpath Partners
Create Medicines$122M · 2026-05-14
Create Medicines$122M · 2026
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
Pappas Capital
Enlaza Therapeutics$100M · 2024-04-30
Enlaza Therapeutics$100M · Unknown date
Enlaza$100M · Unknown date
Boragen$10M · Unknown date
Thiel Capital
Alloy Therapeutics$40M · 2026-04
Alloy Therapeutics$40M · 2026
Alloy Therapeutics$40M · Unknown date
Alloy Therapeutics$40M · Unknown date
Alaska Permanent Fund Corporation
Codiak Biosciences$76M · 2017-11-29
Codiak Biosciences$80M · 2015-11-17
Codiak Biosciences$61M · Unknown date
Bristol Myers Squibb
Dispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23
Autobahn Therapeutics$76M · 2020-06-09
Fidelity Management & Research Company
Mirador Tx$400M · 2024-03-21Karuna Therapeutics$82M · 2019-03-18
Nohla Therapeutics$45M · 2018-05-15
General Catalyst
Eikon Therapeutics$350M · 2025-02-26
Georgiamune$75M · 2023
Odyssey Therapeutics$168M · 2022-10-13
Leaps by Bayer
Paratus Sciences$— · 2023-02-28
Mozart Therapeutics$55M · 2021-10-26
SonoThera$125M · Unknown date
Lightspeed
Seismic Therapeutic$121M · 2023
Enlaza Therapeutics$100M · Unknown date
Enlaza$100M · Unknown date
Logos Capital
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Asher Bio$108M · 2021-09-01
Samsara BioCapital
Enlaza Therapeutics$100M · 2024-04-30
Autobahn Therapeutics$76M · 2020-06-09
Enlaza Therapeutics$100M · Unknown date
Sanofi Ventures
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Rome$72M · Unknown date
Venrock Healthcare Capital Partners
Mirador Therapeutics$250M · 2025
AiRNA$155M · Unknown date
Metacrine$65M · Unknown date
AbbVie
Magnolia Neurosciences$31M · 2018-08-14
Petra Pharma$48M · 2016-01-06
Atlas Venture
Remix Therapeutics$60M · 2024-01-03
Remix Therapeutics$81M · 2020-12-08
Avalon Capital Group
Enlaza Therapeutics$100M · Unknown date
Enlaza$100M · Unknown date
BECO Capital
Paratus Sciences$— · 2023-02-28
Codiak Biosciences$76M · 2017-11-29
Canaan Partners
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Deerfield
Bitterroot Bio$145M · 2023-06-07Bitterroot$145M · 2023
Fidelity Investments
Codiak Biosciences$80M · 2015-11-17
Codiak Biosciences$61M · Unknown date
Flagship Pioneering
Codiak Biosciences$80M · 2015-11-17
Boragen$10M · Unknown date
Illumina Ventures
Encoded Therapeutics$104M · 2019-06-26
SonoThera$125M · Unknown date
Koch Disruptive Technologies
Bitterroot Bio$145M · 2023-06-07Bitterroot$145M · 2023
Longwood Fund
Tome Biosciences$213M · 2023-12-12
ImmuneID$50M · Unknown date
Moore Strategic Ventures
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
MRL Ventures Fund
Mozart Therapeutics$55M · 2021-10-26
LifeMine Therapeutics$55M · 2017-09-18
Partnership Fund for New York City
Magnolia Neurosciences$31M · 2018-08-14
Petra Pharma$48M · 2016-01-06
Presight Capital
Alloy Therapeutics$75M · 2021-04-02
Alloy Therapeutics$75M · 2021
Primary Venture Partners
Myeloid Therapeutics$73M · 2023-05-18
Codiak Biosciences$80M · 2015-11-17
Qatar Investment Authority
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
Redmile Group
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
RiverVest Venture Partners
OncoResponse, Inc.$40M · 2018-09-11
OncoResponse$40M · 2018-09-11
S32
Aspen Neuroscience$147M · 2022-05-09
Aspen Neuroscience$6M · 2019-12-12
Stanford University
Dispatch Bio$216M · 2025-07-23
Dispatch Biotherapeutics$216M · 2025-07-23
T. Rowe Price
Eikon Therapeutics$350M · 2025-02-26
Odyssey Therapeutics$168M · 2022-10-13
Agent Capital
TRexBio$84M · 2024-11-13
Alex Kolicich
Alloy Therapeutics$40M · 2026-04
Alphabet Inc.
Seismic Therapeutic$121M · 2023
Altitude Life Science Ventures
Mozart Therapeutics$55M · 2021-10-26
Andreessen Horowitz
Orbital Therapeutics$270M · 2023-04-26
Avalon BioVentures
Arialys Therapeutics$58M · 2023-09-12
Avalon Ventures
Enlaza Therapeutics$100M · 2024-04-30
Axon Partners Group
Aspen Neuroscience$6M · 2019-12-12
Bessemer Venture Partners
Seismic Therapeutic$121M · 2023
Blue Owl Healthcare Opportunities
Mirador Tx$400M · 2024-03-21
Boxer Capital
Seismic Therapeutic$121M · 2023
Boyu Capital
LifeMine Therapeutics$55M · 2017-09-18
Bregua Corporation
Enlaza Therapeutics$100M · 2024-04-30
BVF Partners L.P.
Autobahn Therapeutics$76M · 2020-06-09
Catalys Pacific
Arialys Therapeutics$58M · 2023-09-12
ClavystBio
Paratus Sciences$— · 2023-02-28
Colt Ventures
Odyssey Therapeutics$168M · 2022-10-13
Cowen Healthcare Investments
Autobahn Therapeutics$76M · 2020-06-09
Decent Capital
Encodia$75M · 2021-01-27
Domain Associates
Aspen Neuroscience$6M · 2019-12-12
Duquesne Family Office
SonoThera$125M · Unknown date
Echo Health Ventures
Aitia$28M · 2019-07-09
EDBI
Aspen Neuroscience$147M · 2022-05-09
Eventide Asset Management
Karuna Therapeutics$82M · 2019-03-18
F-Prime Capital
Neumora Therapeutics, Inc.$— · 2021-10-07
Farallon Capital Management
Mirador Therapeutics$250M · 2025
Foresite Capital
Remix Therapeutics$81M · 2020-12-08
Franklin Templeton
Metacrine$65M · Unknown date
Frazier Healthcare Partners
Enlaza$100M · Unknown date
Frazier Life Sciences
Enlaza Therapeutics$100M · 2024-04-30
FUJIFILM Corporation
Tome Biosciences$213M · 2023-12-12
Gary Loveman
Aitia$28M · 2019-07-09
J.P. Morgan Private Capital Life Sciences
Enlaza Therapeutics$100M · 2024-04-30
Janus Henderson Investors
TRexBio$50M · 2026-01-27
Laurion Capital Management
TRexBio$85M · 2022-03-08
Lifeforce Capital
Aspen Neuroscience$147M · 2022-05-09
Lightspeed Venture Partners
Enlaza Therapeutics$100M · 2024-04-30
Luma Bio-IT
Alloy Therapeutics$75M · 2021-04-02
Lux Capital
Eikon Therapeutics$350M · 2025-02-26
Mass General Brigham Ventures
Rome$72M · Unknown date
Menlo Ventures
Encoded Therapeutics$104M · 2019-06-26
Merck Global Health Innovation Fund
Aitia$28M · 2019-07-09
Mission BioCapital
Asher Bio$108M · 2021-09-01
Mountain Group Partners
Boragen$10M · Unknown date
MPM BioImpact
Arialys Therapeutics$58M · 2023-09-12
Mubadala Capital
Alloy Therapeutics$75M · 2021-04-02
Nextech Invest Ltd.
AiRNA$155M · Unknown date
Northpond Ventures
Encodia$75M · 2021-01-27
Okapi Venture Capital
Ubiq$6M · Unknown date
Ona Capital
Codiak Biosciences$76M · 2017-11-29
Ono Venture Investment
AiRNA$60M · Unknown date
OrbiMed
Aspen Neuroscience$6M · 2019-12-12
Partner Fund Management
Karuna Therapeutics$82M · 2019-03-18
Peter Thiel
Alloy Therapeutics$75M · 2021-04-02
Pivotal bioVenture PartnersKaruna Therapeutics$82M · 2019-03-18
Polaris Innovation Fund
Neumora Therapeutics, Inc.$— · 2021-10-07
Premier Partners
Nohla Therapeutics$45M · 2018-05-15
re.Mind Capital
Neumora Therapeutics, Inc.$— · 2021-10-07
Redpoint Ventures
Odyssey Therapeutics$168M · 2022-10-13
Regeneron Ventures
Enlaza Therapeutics$100M · 2024-04-30
RTW Investments, LP
Encoded Therapeutics$104M · 2019-06-26
Sands Capital
Karuna Therapeutics$82M · 2019-03-18
Section 32
Aspen Neuroscience$6M · 2019-12-12
ShangBay Capital
IGGENIX$25M · 2021-07-27
Sofinnova Partners
Mozart Therapeutics$55M · 2021-10-26
Soros Fund Management
Eikon Therapeutics$350M · 2025-02-26
StepStone Group
Eikon Therapeutics$350M · 2025-02-26
Surveyor Capital
Remix Therapeutics$60M · 2024-01-03
Syngenta Group Ventures
Boragen$10M · Unknown date
Tao Capital Partners
Encodia$75M · 2021-01-27
Tekla Capital Management
ImmuneID$50M · Unknown date
TenOneTen Ventures
Ubiq$6M · Unknown date
The Cigna Group Ventures
Aitia$28M · 2019-07-09
The Column Group
Remix Therapeutics$81M · 2020-12-08
Third Rock Ventures
Asher Bio$108M · 2021-09-01
UC Investments
Eikon Therapeutics$350M · 2025-02-26
Ulysses Diversified Holdings
Alloy Therapeutics$75M · 2021-04-02
Venrock
Encoded Therapeutics$104M · 2019-06-26
Vertex Ventures HC
SonoThera$125M · Unknown date
Vineeta Agarwala
Orbital Therapeutics$270M · 2023-04-26
W.T.T. Investment Ltd.
Remix Therapeutics$60M · 2024-01-03
Wellington Management
Asher Bio$108M · 2021-09-01
WuXi AppTec
LifeMine Therapeutics$55M · 2017-09-18



